By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kineta Inc. 

307 Westlake Ave North
Suite 200
Seattle  Washington  98109  U.S.A.
Phone: 206-378-0400 Fax: 206-378-0408



Start Up

Company News
Kineta Inc.’s Novel Antiviral Compounds Inhibit Broad Array Of Emerging And Current Viruses Including Ebola 3/26/2015 9:06:22 AM
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015 10:23:49 AM
Kineta Inc. Completes Enrollment Of First Psoriasis Clinical Trial Using Novel ShK-186 1/21/2015 10:51:27 AM
Kineta Inc. Announces The Opening Of The First Psoriasis Clinical Trial Using Novel ShK-186 10/14/2014 8:27:27 AM
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014 7:56:44 AM
Kineta Inc. And RLB Holdings Announce New Joint Venture To Address High-Need Therapeutics Including Autoimmune Diseases 4/15/2014 9:26:47 AM
Kineta Inc. Announces Enrollment Of First Subject In 1B Clinical Trial 11/26/2013 9:25:21 AM
RLB Holdings and Kineta Inc. Announce Second Investment 2/6/2013 2:02:53 PM
Kineta Inc. Adds to Its Pipeline of Venom-Derived Drug Candidates, In-licenses Conotoxin Program for Non-Narcotic Pain Relief 1/25/2013 9:31:55 AM
Kineta Inc. Announces Regulatory Clearance to Initiate a Phase 1 Clinical Trial for ShK-186 8/21/2012 9:34:38 AM